KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Supernus Pharmaceuticals (SUPN) Interest Coverage Ratio (2016 - 2023)

Supernus Pharmaceuticals (SUPN) has disclosed Interest Coverage Ratio for 13 consecutive years, with 19.33 as the latest value for Q2 2023.

  • On a quarterly basis, Interest Coverage Ratio fell 408.31% to 19.33 in Q2 2023 year-over-year; TTM through Mar 2024 was 14.94, a 300.91% decrease, with the full-year FY2023 number at 2.18, down 133.44% from a year prior.
  • Interest Coverage Ratio was 19.33 for Q2 2023 at Supernus Pharmaceuticals, down from 3.44 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 21.54 in Q4 2022 to a low of 19.33 in Q2 2023.
  • A 5-year average of 4.58 and a median of 5.87 in 2021 define the central range for Interest Coverage Ratio.
  • Peak YoY movement for Interest Coverage Ratio: surged 1996.02% in 2022, then tumbled 408.31% in 2023.
  • Supernus Pharmaceuticals' Interest Coverage Ratio stood at 7.07 in 2019, then fell by 0.17% to 7.05 in 2020, then crashed by 85.43% to 1.03 in 2021, then soared by 1996.02% to 21.54 in 2022, then tumbled by 189.73% to 19.33 in 2023.
  • Per Business Quant, the three most recent readings for SUPN's Interest Coverage Ratio are 19.33 (Q2 2023), 3.44 (Q1 2023), and 21.54 (Q4 2022).